The record date for the payment of final dividend for the financial year 2025-26 is submitted.

August 14, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Script Code: 526783 Dear Sir / Madam, Sub: Annual General Meeting of the Members of the Company and Intimation of Record Date under Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject, we wish to inform that: 1. the 32nd Annual General Meeting (‘AGM’) of the Members of the Company is scheduled to be held on Wednesday, September 09, 2026, at 10:30 AM (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM) in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. 2. as already intimated, the Board at its meeting held on May 20, 2026, had recommended a Final Dividend of INR 4.00 per equity share of INR 10 each, fully paid-up, (40%) for the financial year 2025-26 subject to the approval of the Members at the aforesaid ensuing AGM of the Company. On such approval, the Dividend would be paid on or before October 08, 2026, to those members whose names appear on the Register of Members of the Company and Beneficial Owners as per the list to be furnished by the Depositories as at the closing hours on as on Wednesday, September 02, 2026 (Record Date). We request you to kindly take the above on record. For Dr. Agarwal’s Eye Hospital Limited Meenakshi Jayaraman Company Secretary and Compliance Officer NOTICE TO THE MEMBERS Annual Report 2025-26 1 NOTICE TO THE MEMBERS NOTICE IS HEREBY GIVEN that the Thirty Second (32nd) and Auditors) Rules, 2014 (including any statutory Annual General Meeting of the members of Dr. Agarwal’s modification(s) or re-enactment(s) thereof, for the Eye Hospital Limited (the Company) will be held on time being in force), the remuneration of 90,000 Wednesday, September 09, 2026 at 10.30 AM through video (Rupees Ninety Thousand only) plus applicable taxes conferencing (VC) /other audio visual means (OAVM), to and reimbursement of actual out-of-pocket expenses transact the following business. payable to M/s. BY & Associates, Cost Accountants (Firm Registration No. 003498), appointed by the Board ORDINARY BUSINESS: of Directors of the Company to conduct the audit of the cost records of the Company for the financial year 1. To receive, consider and adopt the audited financial 2025–26, be and is hereby ratified and confirmed. statement of the Company for the financial year ended March 31, 2026, along with the report of the board 5. Approval of revision in remuneration of Dr. Amar of directors and auditors thereon and in this regard, Agarwal, Chairman cum Managing Director (DIN: to consider and if thought fit, to pass the following 00435684) resolution as Ordinary Resolution: To consider and if thought fit, to pass the following “RESOLVED THAT the audited financial statement of resolution as a Special Resolution: the Company for the financial year ended March 31, 2026 and the reports of the Board of Directors and “RESOLVED THAT in accordance with the provisions Auditors thereon, as circulated to the members, be and of Regulation 17(6)(e) of SEBI (LODR) Regulations, are hereby considered and adopted.” 2015 and other applicable provisions, if any, and Section 197, 198 and other applicable provisions, if 2. To declare dividend on equity shares for the financial any, of the Companies Act, 2013 read with Schedule year ended March 31, 2026, and in this regard, to V of the Companies Act, 2013 and the rules made consider and if thought fit, to pass the following thereunder, including any amendments, modifications resolution as an Ordinary Resolution: or re- enactments thereof for the time being in force; upon recommendation of the Nomination and “RESOLVED THAT a dividend of ` 4.00 per share Remuneration Committee and the Board of Directors, (40%) on the paid-up capital consisting of 48,32,827 the consent of the members of the Company be and equity shares, absorbing a sum of ` 193.31 lakh as is hereby accorded for revision of remuneration of recommended by the Board, be approved and the Dr. Amar Agarwal (DIN: 00435684), Chairman cum same be and is hereby declared payable for the year Managing Director of the Company, which is in excess ended March 31, 2026.” of threshold limits as prescribed under SEBI(LODR) Regulations, 2015 and Schedule V of the Companies 3. To appoint a director in the place of Dr. Adil Agarwal (DIN Act, 2013 and the Rules made thereunder. 01074272) who retires by rotation and being eligible offers himself for reappointment and in this regard, RESOLVED FURTHER THAT the extent and scope of to consider and if thought fit, to pass the following salary and perquisites of the Director may be altered, resolution as an Ordinary Resolution: enhanced, widened or varied by the Board of Directors in accordance with the provisions of Companies Act, “RESOLVED THAT in accordance with the provisions 2013 and other applicable provisions, however, within of Section 152 and other applicable provisions of the the limits prescribed in the explanatory statement to Companies Act, 2013, Dr. Adil Agarwal (DIN 01074272) item no. 5 as annexed to this notice. who retires by rotation be and is hereby re-appointed as a Director of the Company.” RESOLVED FURTHER THAT the terms and remuneration as set out in the explanatory statement of this resolution shall be deemed to form part hereof and in SPECIAL BUSINESS: the event of inadequacy or absence of profits in any financial year during the currency of the tenure of the 4. Ratification of remuneration to cost auditor for the Chairman cum Managing Director, the remuneration financial year 2025-26 as stated in the Explanatory Statement, and annual performance commission, excluding the perquisites To consider and if thought fit, to pass the following mentioned under Section IV of Part II of the Schedule V resolution as an Ordinary Resolution: of the Act shall be treated as minimum remuneration, subject to limits mentioned under Section II of Part II “RESOLVED THAT pursuant to the provisions of of Schedule V of the Act or such other limit as maybe section 148 and other applicable provisions, if any, of prescribed by the Government from time to time shall the Companies Act, 2013 and the Companies (Audit be paid;. 2 Dr. Agarwal’s Eye Hospital Limited RESOLVED FURTHER THAT the Board of Directors and and writings as may be required to give effect to the Company Secretary of the of the Company be and aforesaid resolution.” are hereby authorized to do all such acts, deeds and things and execute all such documents, instruments By order of the Board and writings as may be required to give effect to the For Dr. Agarwal’s Eye Hospital Ltd. aforesaid resolution.” Sd/- Meenakshi Jayaraman 6. Approval of revision in remuneration of Dr. Athiya Company Secretary and Compliance Officer Agarwal, Whole-Time Director (DIN: 01365659) Place: Chennai To consider and if thought fit, to pass the following Date: August 03, 2026 resolution as a Special Resolution: Notes: “RESOLVED THAT in accordance with the provisions Pursuant to General Circular No(s). 14/2020 dated April 8, of Regulation 17(6)(e) of SEBI (LODR) Regulations, 2020, 17/2020 dated April 13, 2020, 20/2020 dated May 5, 2015 and other applicable provisions, if any, Section 2020 and subsequent circulars issued in this regard, the 197, 198 and other applicable provisions, if any, of latest being General Circular No. 03/2025 dated September the Companies Act, 2013 read with Schedule V of the 22, 2025, (collectively referred to as “MCA Circulars”), the Companies Act, 2013 and the rules made thereunder, 32nd Annual General Meeting (‘ AGM’) of the Company including any amendments, modifications or re- is being conducted through VC/OAVM Facility, without enactments thereof for the time being in force; the physical presence of Members at a common venue. upon recommendation of the Nomination and [Showing first 8,000 characters — download PDF for full document]